Chloroquine and its derivatives exacerbate B19V associated anemia by promoting viral replication

PLoS Neglected Tropical Diseases

Volumn 4, Issue 4, 2010, Pages

  Bönsch, Claudia ^a   Kempf, Christoph ^a,b   Mueller, Ivo ^c   Manning, Laurens ^d   Laman, Moses ^c,d   Davis, Timothy M E ^d   Ros, Carlos ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b CSL Behring AG   (Switzerland)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOQUINOLINE; AMODIAQUINE; ARTEMISININ; ARTESUNATE; BENFLUMETOL; CHLOROQUINE; MEFLOQUINE; N,N DIMETHYLFORMAMIDE; PIPERAQUINE; PRIMAQUINE; PYRIMETHAMINE; ANTIMALARIAL AGENT; SIGNAL PEPTIDE; VIRUS DNA; VIRUS RNA;

ANEMIA; ARTICLE; CHILD; CHILD HEALTH; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHEMA INFECTIOSUM; HUMAN; HUMAN CELL; HUMAN PARVOVIRUS B19; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA SYNTHESIS; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; CASE CONTROL STUDY; CELL LINE; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; INFANT; MALE; PAPUA NEW GUINEA; PARVOVIRUS INFECTION; PRESCHOOL CHILD; VIROLOGY;

ANIMALS; ANTIMALARIALS; CASE-CONTROL STUDIES; CELL LINE; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DNA, VIRAL; FEMALE; HUMANS; INFANT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PAPUA NEW GUINEA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RNA, VIRAL; VIRUS REPLICATION;

EID: 77952332778     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000669     Document Type: Article

References (29)

1. Cossart YE, Field AM, Cant B, Widdow D (1975) Parvovirus-like particles in human sera. Lancet 7898: 72-73.
2. Broliden K, Tolfvenstam T, Norbeck O (2006) Clinical aspects of parvovirus B19 infection. J Intern Med 260: 285-304.
3. Pasvol G (2006) Parvovirus infection, malaria, and anemia in the tropics-a new hidden enemy? J Infect Dis 194: 141-42.
4. Wildig J, Michon P, Siba P, Mellombo M, Ura A, et al. (2006) Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis 194: 146-53.
5. Jones PH, Pickett LC, Anderson MJ, Pasvol G (1990) Human parvovirus infection in children and severe anemia seen in an area endemic for malaria. J Trop Med Hyg 93: 67-70.
6. Yeats J, Daley H, Hardie D (1999) Parvovirus B19 infection does not contribute significantly to severe anemia in children with malaria in Malawi. Eur J Haematol 63: 276-77.
7. Newton CR, Warn PA, Winstanley PA, Peshu N, Pasvol G, et al. (1997) Severe anemia in children living in a malaria endemic area of Kenya. Trop Med Int Health 2: 165-78.
8. Tolfvenstam T, Enbom M, Ghebrekidan H, Rudén U, Linde A, et al. (2000) Seroprevalence of viral childhood infections in Eritrea. J Clin Virol 16: 49-54.
9. Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R (2003) Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis 3: 722-27.
10. Rolain JM, Colson P, Raoult D (2007) Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents 30: 297-308.
11. Maheshwari RK, Srikantan V, Bhartiya D (1991) Chloroquine enhances replication of Semliki Forest virus and encephalomyocarditis virus in mice. J Virol 65: 992-95.
12. Karmali RA, Horrobin DF, Menezs J, Patel P, Musto J (1978) Chloroquine enhances Epstein-Barr virus expression. Nature 275: 444-45.
13. Sadoff L (1973) Antimalarial drugs and Burkitt's lymphoma. Lancet 7840: 1262-63.
14. Wong S, Brown KE (2006) Development of an improved method of detection of infectious parvovirus B19. J Clin Virol 35: 407-13.
15. Bonvicini F, Filippone C, Manaresi E, Zerbini M, Musiani M, et al. (2008) HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. J Gen Virol 89: 3034-38.
16. Pillet S, Fichelson S, Morinet F (2008) Human B19 Erythrovirus In Vitro Replication: What's New?. J Virol 82: 8951-53.
17. Bönsch C, Kempf C, Ros C (2008) Interaction of Parvovirus B19 with Human Erythrocytes Alters Virus Structure and Cell Membrane Integrity. J Virol 82: 11784-91.
18. Karunajeewa HA, Ilett KF, Mueller I, Siba P, Law I, et al. (2008) Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob Agents Chemother 52: 237-43.
19. Laurent F, Saivin S, Chretien P, Magnaval JF, Peyron F, et al. (1993) Pharmacokinetic and pharmacodynamic study of amodiaquine and its two metabolites after a single oral dose in human volunteers. Arzneimittel for schung 43: 612-16.
20. Maitland K, Marsh K (2004) Pathophysiology of severe malaria in children. Acta Tropica 90: 131-40.
21. Vihinen-Ranta M, Kalela A, Mäkinen P, Kakkola L, Marjomäki V, et al. (1998) Intracellular Route of Canine Parvovirus Entry. J Virol 72: 802-06.
22. Mani B, Baltzer C, Valle N, Almendral JM, Kempf C, et al. (2006) Low pHdependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), NVP2 cleavage, and uncoating of the full-length genome. J Virol 80: 1015-24.
23. Cotmore SF, Tattersall P (2007) Parvoviral host range and cell entry mechanisms. Adv Virus Res 70: 183-232.
24. Mani B, Gerber M, Lieby P, Boschetti N, Kempf C, et al. (2007) Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses. Transfusion 47: 1765-74.
25. Suikkanen S, Aaltonen T, Nevalainen M, Vä lilehto O, Lindholm L, et al. (2003) Exploitation of microtubule cytoskeleton and dynein during parvoviral traffic toward the nucleus. J Virol 77: 10270-79.
26. McChesney EW, Banks WF, Fabian RJ (1967) Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the rat. Toxicology And Applied Pharmacology 10: 501-13.
27. Grundmann M, Mikulikova I, Vrublovsky P (1971) Tissue distribution of subcutaneously administered chloroquine in the rat. Arzneim Forsch 21: 573-74.
28. Edwards G, Looareesuwan S, Davies AJ, Wattanagoon Y, Phillips RE, et al. (1988) Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria. Br J Clin Pharmacol 25: 477-85.
29. World Health Organization (2006) Guidelines for the treatment of malaria. Geneva: World Health Organization; (WHO/HTM/MAL/2006.1108).